At a glance
- Originator Nonindustrial source
- Class Analgesics; Oligopeptides
- Mechanism of Action Neurokinin 1 receptor agonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 06 Mar 2001 Preclinical development for Pain in USA (Unknown route)